Dr Vsevolod V Gurevich

All Stories

1. 
   Critical role of the finger loop in arrestin binding to the receptors

   Article • PLoS ONE, March 2019, PLOS

   Dr Vsevolod V Gurevich

2. 
   Heterologous phosphorylation-induced formation of a stability lock permits regulation of inactive receptors by β-arrestins

   Article • Journal of Biological Chemistry, November 2017, American Society for Biochemistry & Molecular Biology (ASBMB)

   Dr Vsevolod V Gurevich

3. 
   Differential manipulation of arrestin-3 binding to basal and agonist-activated G protein-coupled receptors

   Article • Cellular Signalling, August 2017, Elsevier

   Dr Vsevolod V Gurevich

4. 
   Beyond traditional pharmacology: new tools and approaches

   Article • British Journal of Pharmacology, June 2015, Wiley

   Dr Vsevolod V Gurevich

5. 
   GRK3 suppresses L-DOPA-induced dyskinesia in the rat model of Parkinson’s disease via its RGS homology domain

   Article • Scientific Reports, June 2015, Nature

   Dr Vsevolod V Gurevich

6. 
   How genetic errors in GPCRs affect their function: Possible therapeutic strategies

   Article • Genes & Diseases, June 2015, Tsinghua University Press

   Dr Vsevolod V Gurevich

7. 
   C-terminal threonines and serines play distinct roles in the desensitization of rhodopsin, a G protein-coupled receptor

   Article • eLife, April 2015, eLife

   Dr Vsevolod V Gurevich

8. 
   GPCR structure, function, drug discovery and crystallography: report from Academia-Industry International Conference (UK Royal Society) Chicheley Hall, 1–2 September 2014

   Article • Naunyn-Schmiedeberg s Archives of Pharmacology, March 2015, Springer Science + Business Media

   Dr Vsevolod V Gurevich

9. 
   G Protein-coupled Receptor Kinases of the GRK4 Protein Subfamily Phosphorylate Inactive G Protein-coupled Receptors (GPCRs)

   Article • Journal of Biological Chemistry, March 2015, American Society for Biochemistry & Molecular Biology (ASBMB)

   Dr Vsevolod V Gurevich

10. 
    Arrestins

    Article • January 2015, Elsevier

    Dr Vsevolod V Gurevich

11. 
    The Rhodopsin-Arrestin-1 Interaction in Bicelles

    Article • January 2015, Springer Science + Business Media

    Dr Vsevolod V Gurevich

12. 
    Arrestins regulate cell spreading and motility via focal adhesion dynamics

    Article • Molecular Biology of the Cell, December 2014, American Society for Cell Biology (ASCB)

    Dr Vsevolod V Gurevich

13. 
    Arrestin Expression inE. coliand Purification

    Article • December 2014, Wiley

    Dr Vsevolod V Gurevich

14. 
    Overview of Different Mechanisms of Arrestin-Mediated Signaling

    Article • December 2014, Wiley

    Dr Vsevolod V Gurevich

15. 
    Imaging visual arrestin in vivo

    Article • The FASEB Journal, October 2014, Federation of American Societies For Experimental Biology (FASEB)

    Professor Bruce Berkowitz, Dr Vsevolod V Gurevich

16. 
    Peptide Modifications Differentially Alter G Protein-Coupled Receptor Internalization and Signaling Bias

    Article • Angewandte Chemie International Edition, July 2014, Wiley

    Dr Vsevolod V Gurevich

17. 
    Mutations in arrestin-3 differentially affect binding to neuropeptide Y receptor subtypes

    Article • Cellular Signalling, July 2014, Elsevier

    Dr Vsevolod V Gurevich

18. 
    Identification of Receptor Binding-induced Conformational Changes in Non-visual Arrestins

    Article • Journal of Biological Chemistry, May 2014, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Vsevolod V Gurevich

19. 
    Arrestin-3 binds the MAP kinase JNK3α2 via multiple sites on both domains

    Article • Cellular Signalling, April 2014, Elsevier

    Dr Vsevolod V Gurevich

20. 
    Extensive shape shifting underlies functional versatility of arrestins

    Article • Current Opinion in Cell Biology, April 2014, Elsevier

    Dr Vsevolod V Gurevich

21. 
    Arrestin makes T cells stop and become active

    Article • The EMBO Journal, February 2014, Wiley

    Dr Vsevolod V Gurevich

22. 
    Arrestins - Pharmacology and Therapeutic Potential

    Article • January 2014, Springer Science + Business Media

    Dr Vsevolod V Gurevich

23. 
    Rapid degeneration of rod photoreceptors expressing self-association-deficient arrestin-1 mutant

    Article • Cellular Signalling, December 2013, Elsevier

    Dr Vsevolod V Gurevich

24. 
    Arrestin-3 Binds c-Jun N-terminal Kinase 1 (JNK1) and JNK2 and Facilitates the Activation of These Ubiquitous JNK Isoforms in Cells via Scaffolding

    Article • Journal of Biological Chemistry, November 2013, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Vsevolod V Gurevich

25. 
    Arrestins in Apoptosis

    Article • November 2013, Springer Science + Business Media

    Dr Vsevolod V Gurevich

26. 
    Arrestin-Dependent Activation of JNK Family Kinases

    Article • November 2013, Springer Science + Business Media

    Dr Vsevolod V Gurevich

27. 
    Enhanced Phosphorylation-Independent Arrestins and Gene Therapy

    Article • November 2013, Springer Science + Business Media

    Dr Vsevolod V Gurevich

28. 
    Self-Association of Arrestin Family Members

    Article • November 2013, Springer Science + Business Media

    Dr Vsevolod V Gurevich

29. 
    Targeting Individual GPCRs with Redesigned Nonvisual Arrestins

    Article • November 2013, Springer Science + Business Media

    Dr Vsevolod V Gurevich

30. 
    Therapeutic Potential of Small Molecules and Engineered Proteins

    Article • November 2013, Springer Science + Business Media

    Dr Vsevolod V Gurevich

31. 
    Constitutively active rhodopsin mutants causing night blindness are effectively phosphorylated by GRKs but differ in arrestin-1 binding

    Article • Cellular Signalling, November 2013, Elsevier

    Dr Vsevolod V Gurevich

32. 
    Caspase-cleaved arrestin-2 and BID cooperatively facilitate cytochrome C release and cell death

    Article • Cell Death and Differentiation, October 2013, Nature

    Dr Vsevolod V Gurevich

33. 
    JNK3 Enzyme Binding to Arrestin-3 Differentially Affects the Recruitment of Upstream Mitogen-activated Protein (MAP) Kinase Kinases

    Article • Journal of Biological Chemistry, August 2013, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Vsevolod V Gurevich

34. 
    Visual arrestin interaction with clathrin adaptor AP-2 regulates photoreceptor survival in the vertebrate retina

    Article • Proceedings of the National Academy of Sciences, May 2013, Proceedings of the National Academy of Sciences

    Dr Vsevolod V Gurevich

35. 
    Insights into congenital stationary night blindness based on the structure of G90D rhodopsin

    Article • EMBO Reports, April 2013, Wiley

    Dr Vsevolod V Gurevich

36. 
    Critical Role of the Central 139-Loop in Stability and Binding Selectivity of Arrestin-1

    Article • Journal of Biological Chemistry, March 2013, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Vsevolod V Gurevich

37. 
    Structural Determinants of Arrestin Functions

    Article • January 2013, Elsevier

    Dr Vsevolod V Gurevich

38. 
    Involvement of distinct arrestin-1 elements in binding to different functional forms of rhodopsin

    Article • Proceedings of the National Academy of Sciences, December 2012, Proceedings of the National Academy of Sciences

    Dr Vsevolod V Gurevich

39. 
    Engineering Visual Arrestin-1 with Special Functional Characteristics

    Article • Journal of Biological Chemistry, December 2012, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Vsevolod V Gurevich

40. 
    Identification of phosphorylation sites in the COOH-terminal tail of the μ-opioid receptor

    Article • Journal of Neurochemistry, November 2012, Wiley

    Professor Graeme Henderson, Dr Vsevolod V Gurevich

41. 
    Ligand Directed Signaling Differences between Rodent and Human κ-Opioid Receptors

    Article • Journal of Biological Chemistry, October 2012, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Vsevolod V Gurevich

42. 
    Conformation of receptor-bound visual arrestin

    Article • Proceedings of the National Academy of Sciences, October 2012, Proceedings of the National Academy of Sciences

    Dr Vsevolod V Gurevich

43. 
    Synthetic biology with surgical precision: Targeted reengineering of signaling proteins

    Article • Cellular Signalling, October 2012, Elsevier

    Dr Vsevolod V Gurevich

44. 
    Manipulation of Very Few Receptor Discriminator Residues Greatly Enhances Receptor Specificity of Non-visual Arrestins

    Article • Journal of Biological Chemistry, July 2012, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Vsevolod V Gurevich

45. 
    Silent Scaffolds

    Article • Journal of Biological Chemistry, April 2012, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Vsevolod V Gurevich

46. 
    The Origin and Evolution of G Protein-Coupled Receptor Kinases

    Article • PLoS ONE, March 2012, PLOS

    Dr Vsevolod V Gurevich

47. 
    ßarrestin1-biased agonism at human δ-opioid receptor by peptidic and alkaloid ligands

    Article • Cellular Signalling, March 2012, Elsevier

    Dr Vsevolod V Gurevich

48. 
    Role of Receptor-attached Phosphates in Binding of Visual and Non-visual Arrestins to G Protein-coupled Receptors

    Article • Journal of Biological Chemistry, January 2012, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Vsevolod V Gurevich

49. 
    G protein-coupled receptor kinases: More than just kinases and not only for GPCRs

    Article • Pharmacology & Therapeutics, January 2012, Elsevier

    Dr Vsevolod V Gurevich

50. 
    The Effect of Arrestin Conformation on the Recruitment of c-Raf1, MEK1, and ERK1/2 Activation

    Article • PLoS ONE, December 2011, PLOS

    Dr Vsevolod V Gurevich

51. 
    Nonvisual Arrestins Function as Simple Scaffolds Assembling the MKK4–JNK3α2 Signaling Complex

    Article • Biochemistry, December 2011, American Chemical Society (ACS)

    Dr Vsevolod V Gurevich

52. 
    The functional cycle of visual arrestins in photoreceptor cells

    Article • Progress in Retinal and Eye Research, November 2011, Elsevier

    Dr Vsevolod V Gurevich

53. 
    Reduced expression of G protein-coupled receptor kinases in schizophrenia but not in schizoaffective disorder

    Article • Neurobiology of Disease, November 2011, Elsevier

    Dr Vsevolod V Gurevich

54. 
    A Single Mutation in Arrestin-2 Prevents ERK1/2 Activation by Reducing c-Raf1 Binding

    Article • Biochemistry, August 2011, American Chemical Society (ACS)

    Dr Vsevolod V Gurevich

55. 
    Progressive Reduction of its Expression in Rods Reveals Two Pools of Arrestin-1 in the Outer Segment with Different Roles in Photoresponse Recovery

    Article • PLoS ONE, July 2011, PLOS

    Dr Vsevolod V Gurevich

56. 
    Identification of Arrestin-3-specific Residues Necessary for JNK3 Kinase Activation

    Article • Journal of Biological Chemistry, June 2011, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Vsevolod V Gurevich

57. 
    Ubiquitin Ligase Parkin Promotes Mdm2–Arrestin Interaction but Inhibits Arrestin Ubiquitination

    Article • Biochemistry, May 2011, American Chemical Society (ACS)

    Dr Vsevolod V Gurevich

58. 
    Identification of key factors that reduce the variability of the single photon response

    Article • Proceedings of the National Academy of Sciences, April 2011, Proceedings of the National Academy of Sciences

    Dr Vsevolod V Gurevich

59. 
    Few Residues within an Extensive Binding Interface Drive Receptor Interaction and Determine the Specificity of Arrestin Proteins

    Article • Journal of Biological Chemistry, April 2011, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Vsevolod V Gurevich

60. 
    Robust Self-Association Is a Common Feature of Mammalian Visual Arrestin-1

    Article • Biochemistry, March 2011, American Chemical Society (ACS)

    Dr Vsevolod V Gurevich

61. 
    Crystal Structure of Arrestin-3 Reveals the Basis of the Difference in Receptor Binding Between Two Non-visual Subtypes

    Article • Journal of Molecular Biology, February 2011, Elsevier

    Dr Vsevolod V Gurevich

62. 
    Arrestin-1 expression level in rods: balancing functional performance and photoreceptor health

    Article • Neuroscience, February 2011, Elsevier

    Dr Vsevolod V Gurevich

63. 
    Kinetics of Rhodopsin Deactivation and Its Role in Regulating Recovery and Reproducibility of Rod Photoresponse

    Article • PLoS Computational Biology, December 2010, PLOS

    Dr Vsevolod V Gurevich

64. 
    Elucidation of Inositol Hexaphosphate and Heparin Interaction Sites and Conformational Changes in Arrestin-1 by Solution Nuclear Magnetic Resonance

    Article • Biochemistry, December 2010, American Chemical Society (ACS)

    Dr Vsevolod V Gurevich

65. 
    Monomeric Rhodopsin Is Sufficient for Normal Rhodopsin Kinase (GRK1) Phosphorylation and Arrestin-1 Binding

    Article • Journal of Biological Chemistry, October 2010, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Vsevolod V Gurevich

66. 
    Ligand-induced Internalization and Recycling of the Human Neuropeptide Y2Receptor Is Regulated by Its Carboxyl-terminal Tail

    Article • Journal of Biological Chemistry, October 2010, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Vsevolod V Gurevich

67. 
    Lentiviral Overexpression of GRK6 Alleviates L-Dopa-Induced Dyskinesia in Experimental Parkinson's Disease

    Article • Science Translational Medicine, April 2010, American Association for the Advancement of Science

    Dr Vsevolod V Gurevich

68. 
    Custom-designed proteins as novel therapeutic tools? The case of arrestins

    Article • Expert Reviews in Molecular Medicine, April 2010, Cambridge University Press

    Dr Vsevolod V Gurevich

69. 
    Non-visual Arrestins Are Constitutively Associated with the Centrosome and Regulate Centrosome Function

    Article • Journal of Biological Chemistry, January 2010, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Vsevolod V Gurevich

70. 
    The Role of Arrestin α-Helix I in Receptor Binding

    Article • Journal of Molecular Biology, January 2010, Elsevier

    Dr Vsevolod V Gurevich

71. 
    Dynamics of mouse rod phototransduction and its sensitivity to variation of key parameters

    Article • IET Systems Biology, January 2010, the Institution of Engineering and Technology (the IET)

    Dr Vsevolod V Gurevich

72. 
    Enhanced Arrestin Facilitates Recovery and Protects Rods Lacking Rhodopsin Phosphorylation

    Article • Current Biology, May 2009, Elsevier

    Dr Vsevolod V Gurevich

73. 
    Enhanced Arrestin Facilitates Recovery and Protects Rods Lacking Rhodopsin Phosphorylation

    Article • Current Biology, April 2009, Elsevier

    Dr Vsevolod V Gurevich

74. 
    Altered Sensitivity to Rewarding and Aversive Drugs in Mice with Inducible Disruption of cAMP Response Element-Binding Protein Function within the Nucleus Accumbens

    Article • Journal of Neuroscience, February 2009, Society for Neuroscience

    Dr Vsevolod V Gurevich

75. 
    Overexpression of Rhodopsin Alters the Structure and Photoresponse of Rod Photoreceptors

    Article • Biophysical Journal, February 2009, Elsevier

    Dr Vsevolod V Gurevich

76. 
    How Does Arrestin Assemble MAPKs into a Signaling Complex?

    Article • Journal of Biological Chemistry, November 2008, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Vsevolod V Gurevich

77. 
    An Intracellular Loop 2 Amino Acid Residue Determines Differential Binding of Arrestin to the Dopamine D2 and D3 Receptors

    Article • Molecular Pharmacology, September 2008, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Vsevolod V Gurevich

78. 
    A Dopamine D2 Receptor Mutant Capable of G Protein-Mediated Signaling but Deficient in Arrestin Binding

    Article • Molecular Pharmacology, September 2008, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Vsevolod V Gurevich

79. 
    Structure and Function of the Third Intracellular Loop of the 5-Hydroxytryptamine2A Receptor: The Third Intracellular Loop Is α-Helical and Binds Purified Arrestins

    Article • Journal of Neurochemistry, June 2008, Wiley

    Dr Vsevolod V Gurevich

80. 
    A Model for the Solution Structure of the Rod Arrestin Tetramer

    Article • Structure, June 2008, Elsevier

    Dr Vsevolod V Gurevich

81. 
    Rich Tapestry of G Protein-Coupled Receptor Signaling and Regulatory Mechanisms

    Article • Molecular Pharmacology, May 2008, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Vsevolod V Gurevich

82. 
    How and why do GPCRs dimerize?

    Article • Trends in Pharmacological Sciences, May 2008, Elsevier

    Dr Vsevolod V Gurevich

83. 
    Diffusion of the Second Messengers in the Cytoplasm Acts as a Variability Suppressor of the Single Photon Response in Vertebrate Phototransduction

    Article • Biophysical Journal, May 2008, Elsevier

    Dr Vsevolod V Gurevich

84. 
    Arrestins and two receptor kinases are upregulated in Parkinson's disease with dementia

    Article • Neurobiology of Aging, March 2008, Elsevier

    Dr Vsevolod V Gurevich

85. 
    GPCR monomers and oligomers: it takes all kinds

    Article • Trends in Neurosciences, February 2008, Elsevier

    Dr Vsevolod V Gurevich

86. 
    Haloperidol and Clozapine Differentially Affect the Expression of Arrestins, Receptor Kinases, and Extracellular Signal-Regulated Kinase Activation

    Article • Journal of Pharmacology and Experimental Therapeutics, January 2008, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Vsevolod V Gurevich

87. 
    Opposing Effects of Inositol Hexakisphosphate on Rod Arrestin and Arrestin2 Self-Association†

    Article • Biochemistry, January 2008, American Chemical Society (ACS)

    Dr Vsevolod V Gurevich

88. 
    Altered expression and subcellular distribution of GRK subtypes in the dopamine-depleted rat basal ganglia is not normalized by l-DOPA treatment

    Article • Journal of Neurochemistry, November 2007, Wiley

    Dr Vsevolod V Gurevich

89. 
    Cone arrestin binding to JNK3 and Mdm2: conformational preference and localization of interaction sites

    Article • Journal of Neurochemistry, November 2007, Wiley

    Dr Vsevolod V Gurevich

90. 
    Regulation of Arrestin Binding by Rhodopsin Phosphorylation Level

    Article • Journal of Biological Chemistry, September 2007, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Vsevolod V Gurevich

91. 
    Anesthetic considerations during percutaneous nephrolithotomy

    Article • Journal of Clinical Anesthesia, August 2007, Elsevier

    Dr Vsevolod V Gurevich

92. 
    Functional Comparisons of Visual Arrestins in Rod Photoreceptors of Transgenic Mice

    Article • Investigative Ophthalmology & Visual Science, May 2007, Association for Research in Vision and Ophthalmology (ARVO)

    Dr Vsevolod V Gurevich

93. 
    Arrestin Mobilizes Signaling Proteins to the Cytoskeleton and Redirects their Activity

    Article • Journal of Molecular Biology, April 2007, Elsevier

    Dr Vsevolod V Gurevich

94. 
    Structure and function of the visual arrestin oligomer

    Article • The EMBO Journal, March 2007, Wiley

    Dr Vsevolod V Gurevich

95. 
    Each rhodopsin molecule binds its own arrestin

    Article • Proceedings of the National Academy of Sciences, February 2007, Proceedings of the National Academy of Sciences

    Dr Vsevolod V Gurevich

96. 
    Arrestin Binding to Calmodulin: A Direct Interaction Between Two Ubiquitous Signaling Proteins

    Article • Journal of Molecular Biology, December 2006, Elsevier

    Dr Vsevolod V Gurevich

97. 
    The structural basis of arrestin-mediated regulation of G-protein-coupled receptors

    Article • Pharmacology & Therapeutics, June 2006, Elsevier

    Dr Vsevolod V Gurevich

98. 
    Visual and Both Non-visual Arrestins in Their “Inactive” Conformation Bind JNK3 and Mdm2 and Relocalize Them from the Nucleus to the Cytoplasm

    Article • Journal of Biological Chemistry, May 2006, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Vsevolod V Gurevich

99. 
    Soluble Mimics of the Cytoplasmic Face of the Human V1-Vascular Vasopressin Receptor Bind Arrestin2 and Calmodulin

    Article • Molecular Pharmacology, March 2006, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Vsevolod V Gurevich

100. 
     Differential interaction of spin-labeled arrestin with inactive and active phosphorhodopsin

     Article • Proceedings of the National Academy of Sciences, March 2006, Proceedings of the National Academy of Sciences

     Dr Vsevolod V Gurevich

101. 
     Visual Arrestin Binding to Microtubules Involves a Distinct Conformational Change

     Article • Journal of Biological Chemistry, February 2006, American Society for Biochemistry & Molecular Biology (ASBMB)

     Dr Vsevolod V Gurevich

102. 
     Article • Genome Biology, January 2006, Springer Science + Business Media

     Dr Vsevolod V Gurevich

103. 
     The Differential Engagement of Arrestin Surface Charges by the Various Functional Forms of the Receptor

     Article • Journal of Biological Chemistry, December 2005, American Society for Biochemistry & Molecular Biology (ASBMB)

     Dr Vsevolod V Gurevich

104. 
     Crystal Structure of Cone Arrestin at 2.3Å: Evolution of Receptor Specificity

     Article • Journal of Molecular Biology, December 2005, Elsevier

     Dr Vsevolod V Gurevich

105. 
     Conformational Differences Between Arrestin2 and Pre-activated Mutants as Revealed by Hydrogen Exchange Mass Spectrometry

     Article • Journal of Molecular Biology, August 2005, Elsevier

     Dr Vsevolod V Gurevich

106. 
     Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors

     Article • Parkinsonism & Related Disorders, June 2005, Elsevier

     Dr Vsevolod V Gurevich

107. 
     Light-Dependent Redistribution of Arrestin in Vertebrate Rods Is an Energy-Independent Process Governed by Protein-Protein Interactions

     Article • Neuron, May 2005, Elsevier

     Dr Vsevolod V Gurevich

108. 
     Dopamine D1 receptor interaction with arrestin3 in neostriatal neurons

     Article • Journal of Neurochemistry, April 2005, Wiley

     Dr Vsevolod V Gurevich

109. 
     Calmodulin kinase II inhibition protects against structural heart disease

     Article • Nature Reports Stem Cells, March 2005, Springer Science + Business Media

     Dr Tatiana A Vishnivetskaya, Dr Vsevolod V Gurevich

110. 
     l-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brain

     Article • Neurobiology of Disease, March 2005, Elsevier

     Dr Vsevolod V Gurevich

111. 
     Arrestin2 expression selectively increases during neural differentiation

     Article • Journal of Neurochemistry, December 2004, Wiley

     Dr Vsevolod V Gurevich

112. 
     Inhibition of Chemoattractant N-Formyl Peptide Receptor Trafficking by Active Arrestins

     Article • Traffic, November 2004, Wiley

     Dr Vsevolod V Gurevich

113. 
     Preferential Interaction between the Dopamine D2 Receptor and Arrestin2 in Neostriatal Neurons

     Article • Molecular Pharmacology, September 2004, American Society for Pharmacology & Experimental Therapeutics (ASPET)

     Dr Vsevolod V Gurevich

114. 
     Direct Binding of Visual Arrestin to Microtubules Determines the Differential Subcellular Localization of Its Splice Variants in Rod Photoreceptors

     Article • Journal of Biological Chemistry, July 2004, American Society for Biochemistry & Molecular Biology (ASBMB)

     Dr Vsevolod V Gurevich

115. 
     The molecular acrobatics of arrestin activation

     Article • Trends in Pharmacological Sciences, February 2004, Elsevier

     Dr Vsevolod V Gurevich

116. 
     Mapping the Arrestin-Receptor Interface

     Article • Journal of Biological Chemistry, October 2003, American Society for Biochemistry & Molecular Biology (ASBMB)

     Dr Vsevolod V Gurevich

117. 
     The New Face of Active Receptor Bound Arrestin Attracts New Partners

     Article • Structure, September 2003, Elsevier

     Dr Vsevolod V Gurevich

118. 
     Functional Capabilities of anN-Formyl Peptide Receptor−Gαi2Fusion Protein:  Assemblies with G Proteins and Arrestins†

     Article • Biochemistry, June 2003, American Chemical Society (ACS)

     Dr Vsevolod V Gurevich

119. 
     The Interaction of a Constitutively Active Arrestin with the Arrestin-Insensitive 5-HT2A Receptor Induces Agonist-Independent Internalization

     Article • Molecular Pharmacology, May 2003, American Society for Pharmacology & Experimental Therapeutics (ASPET)

     Dr Vsevolod V Gurevich

120. 
     The interaction with the cytoplasmic loops of rhodopsin plays a crucial role in arrestin activation and binding

     Article • Journal of Neurochemistry, February 2003, Wiley

     Dr Vsevolod V Gurevich

121. 
     The Nature of the Arrestin·Receptor Complex Determines the Ultimate Fate of the Internalized Receptor

     Article • Journal of Biological Chemistry, January 2003, American Society for Biochemistry & Molecular Biology (ASBMB)

     Dr Vsevolod V Gurevich

122. 
     Article • Chemical and Petroleum Engineering, January 2003, Springer Science + Business Media

     Dr Vsevolod V Gurevich

123. 
     N -Formyl Peptide Receptor Phosphorylation Domains Differentially Regulate Arrestin and Agonist Affinity

     Article • Journal of Biological Chemistry, November 2002, American Society for Biochemistry & Molecular Biology (ASBMB)

     Dr Vsevolod V Gurevich

124. 
     Transition of Arrestin into the Active Receptor-binding State Requires an Extended Interdomain Hinge

     Article • Journal of Biological Chemistry, September 2002, American Society for Biochemistry & Molecular Biology (ASBMB)

     Dr Vsevolod V Gurevich

125. 
     The Third Intracellular Loop of α2-Adrenergic Receptors Determines Subtype Specificity of Arrestin Interaction

     Article • Journal of Biological Chemistry, August 2002, American Society for Biochemistry & Molecular Biology (ASBMB)

     Dr Vsevolod V Gurevich

126. 
     ARF6: a newly appreciated player in G protein-coupled receptor desensitization

     Article • FEBS Letters, May 2002, Wiley

     Dr Vsevolod V Gurevich

127. 
     Aspartic Acid 564 in the Third Cytoplasmic Loop of the Luteinizing Hormone/Choriogonadotropin Receptor Is Crucial for Phosphorylation-independent Interaction with Arrestin2

     Article • Journal of Biological Chemistry, February 2002, American Society for Biochemistry & Molecular Biology (ASBMB)

     Dr Vsevolod V Gurevich

128. 
     μ-Opioid Receptors Desensitize Less Rapidly than δ-Opioid Receptors Due to Less Efficient Activation of Arrestin

     Article • Journal of Biological Chemistry, February 2002, American Society for Biochemistry & Molecular Biology (ASBMB)

     Dr Vsevolod V Gurevich

129. 
     Arrestin2 and arrestin3 are differentially expressed in the rat brain during postnatal development

     Article • Neuroscience, February 2002, Elsevier

     Dr Vsevolod V Gurevich

130. 
     Conservation of the Phosphate-sensitive Elements in the Arrestin Family of Proteins

     Article • Journal of Biological Chemistry, January 2002, American Society for Biochemistry & Molecular Biology (ASBMB)

     Dr Vsevolod V Gurevich

131. 
     Arrestin Variants Display Differential Binding Characteristics for the PhosphorylatedN-Formyl Peptide Receptor Carboxyl Terminus

     Article • Journal of Biological Chemistry, January 2002, American Society for Biochemistry & Molecular Biology (ASBMB)

     Dr Vsevolod V Gurevich

132. 
     Partial Phosphorylation of theN-Formyl Peptide Receptor Inhibits G Protein Association Independent of Arrestin Binding

     Article • Journal of Biological Chemistry, October 2001, American Society for Biochemistry & Molecular Biology (ASBMB)

     Dr Vsevolod V Gurevich

133. 
     Regulation of Formyl Peptide Receptor Agonist Affinity by Reconstitution with Arrestins and Heterotrimeric G Proteins

     Article • Journal of Biological Chemistry, October 2001, American Society for Biochemistry & Molecular Biology (ASBMB)

     Dr Vsevolod V Gurevich

134. 
     Crystal Structure of β-Arrestin at 1.9 Å

     Article • Structure, September 2001, Elsevier

     Dr Vsevolod V Gurevich

135. 
     Real-time Analysis of G Protein-coupled Receptor Reconstitution in a Solubilized System

     Article • Journal of Biological Chemistry, April 2001, American Society for Biochemistry & Molecular Biology (ASBMB)

     Dr Vsevolod V Gurevich

136. 
     Threonine 180 Is Required for G-protein-coupled Receptor Kinase 3- and β-Arrestin 2-mediated Desensitization of the μ-Opioid Receptor inXenopusOocytes

     Article • Journal of Biological Chemistry, November 2000, American Society for Biochemistry & Molecular Biology (ASBMB)

     Dr Vsevolod V Gurevich

137. 
     An Additional Phosphate-binding Element in Arrestin Molecule

     Article • Journal of Biological Chemistry, October 2000, American Society for Biochemistry & Molecular Biology (ASBMB)

     Dr Vsevolod V Gurevich

138. 
     Conserved Phosphoprotein Interaction Motif Is Functionally Interchangeable between Ataxin-7 and Arrestins †

     Article • Biochemistry, June 2000, American Chemical Society (ACS)

     Dr Vsevolod V Gurevich

139. 
     The ADP ribosylation factor nucleotide exchange factor ARNO promotes β-arrestin release necessary for luteinizing hormone/choriogonadotropin receptor desensitization

     Article • Proceedings of the National Academy of Sciences, May 2000, Proceedings of the National Academy of Sciences

     Dr Vsevolod V Gurevich

140. 
     Arrestin Binding to the M2Muscarinic Acetylcholine Receptor Is Precluded by an Inhibitory Element in the Third Intracellular Loop of the Receptor

     Article • Journal of Biological Chemistry, March 2000, American Society for Biochemistry & Molecular Biology (ASBMB)

     Dr Vsevolod V Gurevich

141. 
     Visual Arrestin Activity May Be Regulated by Self-association

     Article • Journal of Biological Chemistry, July 1999, American Society for Biochemistry & Molecular Biology (ASBMB)

     Dr Vsevolod V Gurevich

142. 
     β-Arrestin-dependent Desensitization of Luteinizing Hormone/Choriogonadotropin Receptor Is Prevented by a Synthetic Peptide Corresponding to the Third Intracellular Loop of the Receptor

     Article • Journal of Biological Chemistry, May 1999, American Society for Biochemistry & Molecular Biology (ASBMB)

     Dr Vsevolod V Gurevich

143. 
     How Does Arrestin Respond to the Phosphorylated State of Rhodopsin?

     Article • Journal of Biological Chemistry, April 1999, American Society for Biochemistry & Molecular Biology (ASBMB)

     Dr Vsevolod V Gurevich

144. 
     A Model for Arrestin’s Regulation: The 2.8 Å Crystal Structure of Visual Arrestin

     Article • Cell, April 1999, Elsevier

     Dr Vsevolod V Gurevich

145. 
     Targeted Construction of Phosphorylation-independent β-Arrestin Mutants with Constitutive Activity in Cells

     Article • Journal of Biological Chemistry, March 1999, American Society for Biochemistry & Molecular Biology (ASBMB)

     Dr Vsevolod V Gurevich

146. 
     A direct role for arrestins in desensitization of the luteinizing hormone/choriogonadotropin receptor in porcine ovarian follicular membranes

     Article • Proceedings of the National Academy of Sciences, January 1999, Proceedings of the National Academy of Sciences

     Dr Vsevolod V Gurevich

147. 
     Molecular events associated with the regulation of signaling by M2 muscarinic receptors

     Article • Life Sciences, January 1999, Elsevier

     Dr Vsevolod V Gurevich

148. 
     The Selectivity of Visual Arrestin for Light-activated Phosphorhodopsin Is Controlled by Multiple Nonredundant Mechanisms

     Article • Journal of Biological Chemistry, June 1998, American Society for Biochemistry & Molecular Biology (ASBMB)

     Dr Vsevolod V Gurevich

149. 
     Agonist-Receptor-Arrestin, an Alternative Ternary Complex with High Agonist Affinity

     Article • Journal of Biological Chemistry, November 1997, American Society for Biochemistry & Molecular Biology (ASBMB)

     Dr Vsevolod V Gurevich

150. 
     Internalization of the m2 Muscarinic Acetylcholine Receptor

     Article • Journal of Biological Chemistry, September 1997, American Society for Biochemistry & Molecular Biology (ASBMB)

     Dr Vsevolod V Gurevich

151. 
     Mechanism of Quenching of Phototransduction

     Article • Journal of Biological Chemistry, July 1997, American Society for Biochemistry & Molecular Biology (ASBMB)

     Dr Vsevolod V Gurevich

152. 
     Arrestin/Clathrin Interaction

     Article • Journal of Biological Chemistry, June 1997, American Society for Biochemistry & Molecular Biology (ASBMB)

     Dr Vsevolod V Gurevich

153. 
     Arrestin with a Single Amino Acid Substitution Quenches Light-Activated Rhodopsin in a Phosphorylation-Independent Fashion†

     Article • Biochemistry, June 1997, American Chemical Society (ACS)

     Dr Vsevolod V Gurevich

154. 
     Role of Arrestins in G-Protein-Coupled Receptor Endocytosis

     Article • January 1997, Elsevier

     Dr Vsevolod V Gurevich

155. 
     β-Arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor

     Article • Nature, October 1996, Nature

     Dr Vsevolod V Gurevich

156. 
     [21] Use of bacteriophage RNA polymerase in RNA synthesis

     Article • January 1996, Elsevier

     Dr Vsevolod V Gurevich

157. 
     Visual Arrestin Binding to Rhodopsin

     Article • Journal of Biological Chemistry, March 1995, American Society for Biochemistry & Molecular Biology (ASBMB)

     Dr Vsevolod V Gurevich

158. 
     In Vitro Transcription: Preparative RNA Yields in Analytical Scale Reactions

     Article • Analytical Biochemistry, August 1994, Elsevier

     Dr Vsevolod V Gurevich

159. 
     Preparative in vitro mRNA synthesis using SP6 and T7 RNA polymerases

     Article • Analytical Biochemistry, June 1991, Elsevier

     Dr Vsevolod V Gurevich

160. 
     Functional expression in vitro of bovine visual rhodopsin

     Article • Protein Engineering Design and Selection, January 1990, Oxford University Press (OUP)

     Dr Vsevolod V Gurevich

161. 
     In vitro synthesis of visual rhodopsin for a protein engineering study

     Article • Journal of Protein Chemistry, June 1989, Springer Science + Business Media

     Dr Vsevolod V Gurevich